Cleveland Biolabs (NASDAQ: CBLI) announced that a maximally tolerated dose has been reached and that dosing has been completed in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE